Bill Text: TX HB1849 | 2019-2020 | 86th Legislature | Enrolled

---

Bill Title: Relating to the possession and administration of epinephrine auto-injectors in day-care centers; limiting liability.

Sponsorship: Bipartisan Bill

Status: (Passed) 2019-06-14 - Effective immediately [HB1849 Detail]

Download: Texas-2019-HB1849-Enrolled.html

---

H.B. No. 1849

AN ACT
relating to the possession and administration of epinephrine
auto-injectors in day-care centers; limiting liability.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Subchapter C, Chapter 42, Human Resources Code,
is amended by adding Section 42.067 to read as follows:
Sec. 42.067. EPINEPHRINE AUTO-INJECTORS; IMMUNITY FROM
LIABILITY. (a) In this section:
(1) "Anaphylaxis" means a sudden, severe, and
potentially life-threatening allergic reaction that occurs when a
person is exposed to an allergen.
(2) "Epinephrine auto-injector" means a disposable
medical drug delivery device that contains a premeasured single
dose of epinephrine intended for use to treat anaphylaxis.
(3) "Physician" means a person who holds a license to
practice medicine in this state.
(b) A physician, or a person who has been delegated
prescriptive authority under Chapter 157, Occupations Code, may
prescribe epinephrine auto-injectors in the name of a day-care
center.
(c) A physician or other person who prescribes epinephrine
auto-injectors under Subsection (b) shall provide the day-care
center with a standing order for the administration of an
epinephrine auto-injector to a person reasonably believed to be
experiencing anaphylaxis.
(d) A standing order under Subsection (c) is not required to
be patient-specific. An epinephrine auto-injector may be
administered under this section to a person without a previously
established physician-patient relationship.
(e) Notwithstanding any other law, supervision or
delegation by a physician is considered adequate if the physician:
(1) periodically reviews the order; and
(2) is available through direct telecommunication as
needed for consultation, assistance, and direction.
(f) An order issued under this section must contain:
(1) the name and signature of the prescribing
physician or other person;
(2) the name of the day-care center to which the order
is issued;
(3) the quantity of epinephrine auto-injectors to be
obtained and maintained under the order; and
(4) the date the order was issued.
(g) A pharmacist may dispense an epinephrine auto-injector
to a day-care center without requiring the name of or any other
identifying information relating to the user.
(h) A day-care center shall store an epinephrine
auto-injector in a secure location that is easily accessible to
employees or volunteers of the day-care center authorized and
trained to administer an epinephrine auto-injector.
(i) Each day-care center is responsible for training
employees in the administration of an epinephrine auto-injector.
The training must:
(1) include information on:
(A) recognizing the signs and symptoms of
anaphylaxis;
(B) administering an epinephrine auto-injector;
(C) the recommended dosages for adults and
children by age and weight, if applicable, and the dosages
available at the center;
(D) implementing emergency procedures, if
necessary, after administering an epinephrine auto-injector; and
(E) the proper disposal of used or expired
epinephrine auto-injectors; and
(2) be completed annually in a formal training session
or through online education.
(j) Each day-care center shall maintain records on the
training required under this section.
(k) Not later than the 10th business day after the date a
day-care center employee administers an epinephrine auto-injector
in accordance with this section, the day-care center shall report
the following information to the persons listed in Subsection (l):
(1) the age of the person who received the
administration of the epinephrine auto-injector;
(2) whether the person who received the administration
of the epinephrine auto-injector was:
(A) a child enrolled in the day-care center;
(B) a day-care center employee or volunteer; or
(C) a visitor to the day-care center;
(3) the physical location where the epinephrine
auto-injector was administered;
(4) the number of doses of epinephrine auto-injector
administered;
(5) the title of the employee who administered the
epinephrine auto-injector; and
(6) any other information required by the executive
commissioner.
(l) The information required by Subsection (k) shall be
reported to:
(1) the owner of the day-care center;
(2) the physician or other person who prescribed the
epinephrine auto-injector;
(3) the commission; and
(4) the Department of State Health Services.
(m) The executive commissioner, in consultation with the
Department of State Health Services, shall adopt rules necessary to
implement this section.
(n) A person who in good faith takes, or fails to take,
action relating to the prescription of an epinephrine auto-injector
to a day-care center or the administration of an epinephrine
auto-injector in a day-care center is immune from civil or criminal
liability or disciplinary action resulting from that action or
failure to act, including:
(1) issuing an order for epinephrine auto-injectors;
(2) supervising or delegating the administration of an
epinephrine auto-injector;
(3) possessing, maintaining, storing, or disposing of
an epinephrine auto-injector;
(4) prescribing an epinephrine auto-injector;
(5) dispensing an epinephrine auto-injector;
(6) administering, or assisting in administering, an
epinephrine auto-injector;
(7) providing, or assisting in providing, training,
consultation, or advice in the development, adoption, or
implementation of policies, guidelines, rules, or plans; or
(8) undertaking any other act permitted or required
under this section.
(o) The immunities and protections provided by this section
are in addition to other immunities or limitations of liability
provided by law.
(p) Notwithstanding any other law, this section does not
create a civil, criminal, or administrative cause of action or
liability or create a standard of care, obligation, or duty that
provides a basis for a cause of action for an act or omission under
this section.
(q) If a day-care center obtains epinephrine auto-injectors
for use as authorized by this section, the day-care center shall
notify each parent of a child enrolled in the center of the center's
policy and procedures relating to the administration of the
epinephrine auto-injectors.
(r) An act or omission described by this section does not
create a cause of action.
SECTION 2. This Act takes effect immediately if it receives
a vote of two-thirds of all the members elected to each house, as
provided by Section 39, Article III, Texas Constitution. If this
Act does not receive the vote necessary for immediate effect, this
Act takes effect September 1, 2019.
______________________________ ______________________________
President of the Senate Speaker of the House
I certify that H.B. No. 1849 was passed by the House on April
2, 2019, by the following vote: Yeas 147, Nays 0, 1 present, not
voting.
______________________________
Chief Clerk of the House
I certify that H.B. No. 1849 was passed by the Senate on May
22, 2019, by the following vote: Yeas 31, Nays 0.
______________________________
Secretary of the Senate
APPROVED: _____________________
Date
_____________________
Governor